U.S. stock market movement | Moderna (MRNA.US) surges 5%, stock price approaches historical high

According to Zhitong Finance APP, on Monday, Moderna (MRNA.US) shares surged more than 8% at the opening, and as of press time, the gain narrowed to over 5%, trading at $229.69, with the stock price approaching a historical high. In the news, on October 17, results from the phase III study of Moderna and Merck's personalized cancer treatment intismeran autogene in combination with Keytruda for melanoma were presented, and reports indicated that the candidate therapy achieved positive progress.